Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Healthcare Biotechnology
Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

Recent & Breaking News (TSX:ONC)

Oncolytics Biotech® Inc. Announces Details of 2014 Annual Meeting of Shareholders

Canada NewsWire June 16, 2014

Media Advisory - Oncolytics Biotech® Inc. to Participate in Jefferies 2014 Global Healthcare Conference

Canada NewsWire June 2, 2014

Oncolytics Biotech® Inc. Announces Nomination of Two New Directors

Canada NewsWire May 21, 2014

Oncolytics Biotech® Inc. Collaborators to Present Positive Brain Cancer Clinical Trial Data at the 50th Annual ASCO Meeting

Canada NewsWire May 20, 2014

Oncolytics Biotech® Inc. Announces First Quarter 2014 Results

Canada NewsWire May 8, 2014

Oncolytics Biotech Inc. Collaborators Present Preclinical Research on Liver Cancer at UK Oncolytic Virus Conference

Canada NewsWire April 14, 2014

Oncolytics Biotech Inc. Collaborators Present Head and Neck Cancer Biomarker Preclinical Research at UK Oncolytic Virus Conference

Canada NewsWire April 14, 2014

Oncolytics Biotech Inc. Collaborators Present Translational Brain Cancer Clinical Data and Immunomodulatory Preclinical Research at UK Oncolytic Virus Conference

Canada NewsWire April 11, 2014

Oncolytics Biotech® Inc. Announces Additional Data from REO 018 Randomized Study of REOLYSIN® in Head and Neck Cancers

Canada NewsWire April 8, 2014

Media Advisory - Oncolytics Biotech® Inc. to Participate in 13th Annual Needham Healthcare Conference

Canada NewsWire April 7, 2014

Oncolytics Biotech Inc. Collaborators to Present Preclinical Research in Multiple Myeloma and Melanoma at AACR 2014 Annual Meeting

Canada NewsWire April 7, 2014

Oncolytics Biotech® Inc. Announces 2013 Year End Results

Canada NewsWire March 13, 2014

MEDIA ADVISORY - Oncolytics Biotech® Inc. to Participate in the 34th Annual Cowen and Company Healthcare Conference

Canada NewsWire March 4, 2014

Oncolytics Biotech® Inc. Announces Initial US$1.0 Million Investment and Up to US$25.0 Million Common Share Purchase Agreement with Lincoln Park Capital Fund, LLC

Canada NewsWire February 27, 2014

Media Advisory - Oncolytics Biotech® Inc. to Participate in 2014 RBC Capital Markets Global Healthcare Conference

Canada NewsWire February 25, 2014

Oncolytics Biotech® Inc. to Present at the 25th Annual Piper Jaffray Healthcare Conference

Canada NewsWire December 3, 2013

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of ONCOLYTICS BIOTECH INC. for Possible Violations of Federal Securities Laws

Business Wire November 22, 2013

Oncolytics Biotech (T.ONC) drops 24% after damning coverage on The Street

Chris Parry November 21, 2013

Oncolytics Biotech (T.ONC) jumps 6% on cancer drug news

Canadian Press November 21, 2013

HOLX, GMCR, ONCY and ZNGA added to NASDAQ Active Stock Watch List at EPR

Accesswire November 21, 2013